B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SUMO1

MOLECULAR TARGET

small ubiquitin like modifier 1

UniProt: P63165NCBI Gene: 73414 compounds

SUMO1 (small ubiquitin like modifier 1) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SUMO1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Cefdinir1.102
2Cefixime1.102
3Hexachlorophene1.102
4Oxytetracycline0.691

About SUMO1 as a Drug Target

SUMO1 (small ubiquitin like modifier 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented SUMO1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SUMO1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.